Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy -... - 0 views
-
According to the published literature, it appeared that 94% of the trials conducted were positive. By contrast, the FDA analysis showed that 51% were positive
-
NEJM reanalyzed the results from 12 antidepressant studies involving over 12,000 patients and found that 40% of studies that found no benefit for antidepressants were omitted. This seriously altered the statistics and is obvious manipulation of data. This brings the current recommendations on antidepressants into serious question.